Clinical Trial Update: Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant [Phase 1]

View source ↗

Summary

Phase 1 study evaluating olaparib in combination with high-dose chemotherapy for relapsed or refractory lymphomas undergoing stem cell transplantation has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Hodgkin Lymphoma
• T-cell Non-hodgkin Lymphoma

Drugs mentioned

• Lynparza (olaparib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Recurrent Diffuse Large B-Cell Lymphoma, Recurrent T-Cell Non-Hodgkin Lymphoma | Phase 1 | Status: COMPLETED